Marignol L - Search Results

1

Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer.

Røe K, Bratland Å, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH. Røe K, et al. Among authors: marignol l. PLoS One. 2013 May 10;8(5):e63723. doi: 10.1371/journal.pone.0063723. Print 2013. PLoS One. 2013. PMID: 23675504 Free PMC article.

2

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Røe K, Mikalsen LT, van der Kogel AJ, Bussink J, Lyng H, Ree AH, Marignol L, Olsen DR. Røe K, et al. Among authors: marignol l. Radiat Oncol. 2012 May 23;7:75. doi: 10.1186/1748-717X-7-75. Radiat Oncol. 2012. PMID: 22621752 Free PMC article.

3

Docetaxel maintains its cytotoxic activity under hypoxic conditions in prostate cancer cells.

Forde JC, Perry AS, Brennan K, Martin LM, Lawler MP, Lynch TH, Hollywood D, Marignol L. Forde JC, et al. Among authors: marignol l. Urol Oncol. 2012 Nov-Dec;30(6):912-9. doi: 10.1016/j.urolonc.2010.08.015. Epub 2010 Dec 21. Urol Oncol. 2012. PMID: 21176881

4

Hypoxia, notch signalling, and prostate cancer.

Marignol L, Rivera-Figueroa K, Lynch T, Hollywood D. Marignol L, et al. Nat Rev Urol. 2013 Jul;10(7):405-13. doi: 10.1038/nrurol.2013.110. Epub 2013 May 28. Nat Rev Urol. 2013. PMID: 23712204 Free PMC article. Review.

5

Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells.

Meunier A, Belle VA, McDermott N, Rivera-Figueroa K, Perry A, Lynch T, Redalen KR, Marignol L. Meunier A, et al. Among authors: marignol l. Heliyon. 2016 May 5;2(5):e00104. doi: 10.1016/j.heliyon.2016.e00104. eCollection 2016 May. Heliyon. 2016. PMID: 27441277 Free PMC article.

6

Hypoxia in prostate cancer: a powerful shield against tumour destruction?

Marignol L, Coffey M, Lawler M, Hollywood D. Marignol L, et al. Cancer Treat Rev. 2008 Jun;34(4):313-27. doi: 10.1016/j.ctrv.2008.01.006. Epub 2008 Mar 10. Cancer Treat Rev. 2008. PMID: 18334284 Review.

7

The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.

Foley R, Marignol L, Thomas AZ, Cullen IM, Perry AS, Tewari P, O'Grady A, Kay E, Dunne B, Loftus B, Watson WR, Fitzpatrick JM, Woodson K, Lehman T, Hollywood D, Lynch TH, Lawler M. Foley R, et al. Among authors: marignol l. Cancer Biol Ther. 2009 Jan;8(2):118-24. doi: 10.4161/cbt.8.2.7086. Epub 2009 Feb 1. Cancer Biol Ther. 2009. PMID: 19106642

8

Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells.

Hennessey D, Martin LM, Atzberger A, Lynch TH, Hollywood D, Marignol L. Hennessey D, et al. Among authors: marignol l. Urol Oncol. 2013 Oct;31(7):1106-16. doi: 10.1016/j.urolonc.2011.10.008. Epub 2011 Nov 29. Urol Oncol. 2013. PMID: 22130126

9

Targeting notch in prostate cancer--combination is the key.

Marignol L. Marignol L. Nat Rev Urol. 2014 Jul;11(7):419. doi: 10.1038/nrurol.2013.110-c3. Epub 2014 Jul 1. Nat Rev Urol. 2014. PMID: 24980190 No abstract available.

10

In vitro and in vivo characterization of [⁶⁴Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.

Liu T, Dahle MA, Lystad MH, Marignol L, Karlsen M, Redalen KR. Liu T, et al. Among authors: marignol l. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3576-3588. doi: 10.1007/s00259-023-06310-4. Epub 2023 Jun 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37382663 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page